| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6171195 | Contraception | 2015 | 6 Pages |
Abstract
This secondary analysis of a phase 3 clinical trial of a new weekly low-dose LNG and EE contraceptive patch, which used assessment by both investigators and participants, observed a low incidence of skin irritation, pruritus and patch detachment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Andrew M. Kaunitz, David Portman, Carolyn L. Westhoff, Daniel R. Jr., David F. Archer, Marie Foegh,